≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Universal eryhrodermia, KELA reimbursement

MESH PheWeb

L12_ERYTHRO_KELA

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 134

369

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

369

diagram downward connector

Check minimum number of events None

369

diagram downward connector

Include endpoints None

369

diagram downward connector
L12_ERYTHRO_KELA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 369 127 242
Unadjusted prevalence (%) 0.10 0.06 0.15
Mean age at first event (years) 48.25 45.41 49.74

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.57 [0.64, 3.87] 3.2e-1 61
15 years 0.01 1.09 [0.47, 2.52] 8.4e-1 28
5 years 0.00 1.95 [0.92, 4.16] 8.3e-2 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ERYTHRO_KELA – Universal eryhrodermia, KELA reimbursement
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Universal eryhrodermia, KELA reimbursement
after Universal eryhrodermia, KELA reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Universal eryhrodermia, KELA reimbursement

↥